Stella Pharma Corp. Hits Day High with 15.38% Surge in Stock Price

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, gaining 15.38% as of April 16, 2026. The stock reached an intraday high of JPY 750.00, showcasing its volatility and responsiveness to market conditions. In terms of performance metrics, Stella Pharma Corp. has demonstrated impressive year-to-date growth of 269.46%, significantly outperforming the Japan Nikkei 225, which has risen by 18.23% during the same period. Over the past year, the stock has achieved a remarkable 139.62% increase, while its one-month performance stands at 81.16%. However, it is important to note that the company has faced challenges, including a negative EBITDA of Rs. -55.52 crore and a low return on equity of -6.21%. Despite these hurdles, the stock's recent performance highlights its potential for volatility in the market. Investors may want to keep an eye on Stella Pharma Corp. as it navigates its current financial landscape.